WBD, RIVN, SQ, LYV and more
Check out the companies making headlines in midday trading. Warner Bros. Discovery — Shares dropped 9.9% after the media conglomerate posted disappointing fourth-quarter results and failed to give 2024 free…
2024-04-24 20:00:06
Check out the companies making headlines in midday trading. Warner Bros. Discovery — Shares dropped 9.9% after the media conglomerate posted disappointing fourth-quarter results and failed to give 2024 free…
For many struggling with obesity, new medications have been “a gift,” as Oprah Winfrey recently described it in declaring she was “done with the shaming.” Investors in drug manufacturers Novo…
An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. David W. Cerny | Reuters The health-care sector has wiped out much…
Analysts are largely optimistic about a new class of anti-obesity medications following a landmark study released over the weekend. Novo Nordisk ‘s Select study of about 17,500 people found the…
Check out the companies making headlines in premarket trading. Fortinet — Shares dropped 23.1% after the cybersecurity company missed earnings expectations and gave a weak outlook for the current quarter.…
Check out the companies making headlines in midday trading. Expedia — Shares surged nearly 19% Friday, a day after the vacation booking platform delivered a stronger-than-expected earnings report for the…
Check out the companies making headlines before the bell: Rivian Automotive — Shares popped 3.3% in the premarket. Evercore ISI upgraded Rivian Automotive to outperform from in line, and raised…
More than 40% of adults in the U.S. are obese. That’s a big number, which makes the group a force to be reckoned with if their habits start to change…
GM workers with the UAW Local 2250 union strike outside the General Motors Wentzville Assembly Plant in Wentzville, Missouri, Sept. 15, 2023. Michael B. Thomas | Getty Images Check out…
As new weight loss medications garnered buzz last year, analysts’ forecasts signaled these drugs would be blockbusters, with some of the highest estimates calling for peak sales of at least…